<DOC>
	<DOCNO>NCT02765945</DOCNO>
	<brief_summary>This second phase study design determine immunological effect long-term exercise risk factor ischemic heart disease ( phase 1 ) osteoporosis ( phase 2 ) . The result indicate six month moderate intensity exercise reduce bone resorption increase secretion anti-osteoclastogenic cytokine peripheral blood mononuclear cell .</brief_summary>
	<brief_title>Exercise Modulator Immunological Risk Factors Osteoporosis</brief_title>
	<detailed_description>In trial involve 43 healthy adult investigator measure effect six month supervise exercise spontaneous phytohemagglutinin-induced production osteoclastogenic cytokine ( interleukin-1α , tumor necrosis factor-α ) , anti-osteoclastogenic cytokine ( transform growth factor-β , interleukins 4 and10 ) , pleiotropic cytokine variable effect osteoclastogenesis ( interferon-γ , interleukin-6 ) , T cell growth differentiation factor ( interleukins 2 12 ) peripheral blood mononuclear cell . The investigator also measure lymphocyte phenotype , serum marker bone formation ( osteocalcin ) , bone resorption ( C-terminal telopeptides Type I collagen ) , bone homeostasis ( estradiol , vitamin D2 , testosterone , parathyroid hormone , insulin-like growth factor ) .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Normal exercise treadmill test Any medical condition would prevent participation six month exercise program</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Exercise</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Cytokines</keyword>
</DOC>